tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Aptamer Group Advances Enzyme Modulation Projects with New Licensing Opportunities
Company AnnouncementsAptamer Group Advances Enzyme Modulation Projects with New Licensing Opportunities
1d ago
Aptamer Group Secures Contract Extension with Global Pharma Giant
PremiumCompany Announcements
Aptamer Group Secures Contract Extension with Global Pharma Giant
5d ago
Aptamer Group to Host Technical Development Webinar
PremiumCompany Announcements
Aptamer Group to Host Technical Development Webinar
15d ago
Aptamer Group Announces Investor Webinar to Discuss Recent Progress
PremiumCompany Announcements
Aptamer Group Announces Investor Webinar to Discuss Recent Progress
23d ago
Aptamer Group PLC Reports Strong Revenue Growth and Strategic Partnerships
PremiumCompany Announcements
Aptamer Group PLC Reports Strong Revenue Growth and Strategic Partnerships
23d ago
Aptamer Group’s General Meeting Approves Share Issuance
PremiumCompany AnnouncementsAptamer Group’s General Meeting Approves Share Issuance
1M ago
Aptamer Group Expands Collaboration with Unilever for Deodorant Innovation
Premium
Company Announcements
Aptamer Group Expands Collaboration with Unilever for Deodorant Innovation
1M ago
Aptamer Group Issues Shares for Director Fees
Premium
Company Announcements
Aptamer Group Issues Shares for Director Fees
1M ago
Aptamer Group Plc Announces Major Shareholding Change
PremiumCompany Announcements
Aptamer Group Plc Announces Major Shareholding Change
2M ago
Aptamer Group Announces General Meeting Following £2.0 Million Fundraising Proposal
PremiumCompany Announcements
Aptamer Group Announces General Meeting Following £2.0 Million Fundraising Proposal
2M ago
Aptamer Group Raises £2 Million to Boost Optimer® Technology Commercialization
PremiumCompany Announcements
Aptamer Group Raises £2 Million to Boost Optimer® Technology Commercialization
2M ago
Aptamer Group Advances Liver Fibrosis Treatment with Optimer® Breakthrough
PremiumCompany Announcements
Aptamer Group Advances Liver Fibrosis Treatment with Optimer® Breakthrough
2M ago
Aptamer Group Enters Strategic Partnership to Develop Optimer®-Fc Reagent
PremiumCompany AnnouncementsAptamer Group Enters Strategic Partnership to Develop Optimer®-Fc Reagent
2M ago
Aptamer Group Expands Collaboration with Unilever for New Odour Control Solutions
Premium
Company Announcements
Aptamer Group Expands Collaboration with Unilever for New Odour Control Solutions
3M ago
Aptamer Group Unveils Promising Data on Optimer Platform for Fibrotic Diseases
Premium
Company Announcements
Aptamer Group Unveils Promising Data on Optimer Platform for Fibrotic Diseases
3M ago
Aptamer Group Secures New Contracts and Licensing Agreements, Boosting Growth
PremiumCompany Announcements
Aptamer Group Secures New Contracts and Licensing Agreements, Boosting Growth
3M ago
Aptamer Group Advances Alzheimer’s Test with New ELISA Format and Royalty Agreement
PremiumCompany Announcements
Aptamer Group Advances Alzheimer’s Test with New ELISA Format and Royalty Agreement
4M ago
Aptamer Group Enters Licensing Deal for Swine Vaccine Adjuvants
PremiumCompany Announcements
Aptamer Group Enters Licensing Deal for Swine Vaccine Adjuvants
4M ago
Aptamer Group Unveils Breakthrough in Targeted Gene Therapy for Liver Fibrosis
PremiumCompany Announcements
Aptamer Group Unveils Breakthrough in Targeted Gene Therapy for Liver Fibrosis
4M ago
Aptamer Group Reports Revenue Growth and Strategic Advances in Interim Results
PremiumCompany AnnouncementsAptamer Group Reports Revenue Growth and Strategic Advances in Interim Results
6M ago
Aptamer Group Plc Announces Change in Major Holdings
Premium
Company Announcements
Aptamer Group Plc Announces Change in Major Holdings
6M ago
Aptamer Group to Announce Interim Results and Host Investor Presentation
Premium
Company Announcements
Aptamer Group to Announce Interim Results and Host Investor Presentation
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >